Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 21 matching records.
21 results — page 1 of 1
- Level BRandomized Controlled TrialPubMed
Safety profile of autologous adipose-derived stromal vascular fraction in clinical use: an exhaustive literature review.
Randomized Controlled Trial on Systemic / IV, published in Stem Cell Res Ther (2026) — summary generated from the PubMed abstract.
- 2026
Stem Cell Res Ther3 citations - Level ASystematic ReviewPubMed
Adipose-Derived Stem Cell, Stromal Vascular Fraction, and Regenerative Cell Enrichment in Fat Grafting: A Systematic Review of Safety and Functional Outcomes.
Systematic Review on Facial Rejuvenation, published in Cureus (2025) — summary generated from the PubMed abstract.
- 2025
Cureus - Level CProspective StudyPubMed
Clinical Evaluation of Safety and Efficacy of a Central Current Good Manufacturing Practices Laboratory Produced Autologous Adipose-Derived Stromal Vascular Fraction Cell Therapy Product for the Treatment of Knee Osteoar
Prospective Study on Knee Osteoarthritis, Osteoarthritis, published in Stem Cells Dev (2024) — summary generated from the PubMed abstract.
- 2024
Stem Cells Dev5 citations - Level DAnimal StudyPubMed
Adipose-derived mesenchymal stromal cells: A study on safety and efficacy in ocular inflammation.
Animal Study on Immune Modulation, published in Ocul Surf (2024) — summary generated from the PubMed abstract.
- 2024
Ocul Surf3 citations - Level BClinical TrialPubMed
Safety of adipose-derived stromal vascular fraction cells to treat Parkinson's disease.
Clinical Trial with a reported sample of 9 on Neuroinflammation, Chronic Inflammation, Immune Modulation, published in Parkinsonism Relat Disord (2024) — summary generated from the PubMed abstract.
- 2024
- n = 9
Parkinsonism Relat Disord2 citations - Level BClinical TrialPubMed
Safety and feasibility of autologous adipose-derived stromal vascular fraction in the treatment of keloids: a phase one randomized controlled pilot trial.
Clinical Trial with a reported sample of 8 on Scar, published in Am J Stem Cells (2023) — summary generated from the PubMed abstract.
- 2023
- n = 8
Am J Stem Cells5 citations - Level BClinical TrialPubMed
Safety and Feasibility of Intradiscal Administration of Matrilin-3-Primed Adipose-Derived Mesenchymal Stromal Cell Spheroids for Chronic Discogenic Low Back Pain: Phase 1 Clinical Trial.
Clinical Trial on Back Pain, Disc Degeneration, published in Int J Mol Sci (2023) — summary generated from the PubMed abstract.
- 2023
Int J Mol Sci11 citations - Level DNarrative ReviewPubMed
The Crosstalk Between Adipose-Derived Stem or Stromal Cells (ASC) and Cancer Cells and ASC-Mediated Effects on Cancer Formation and Progression-ASCs: Safety Hazard or Harmless Source of Tropism?
Narrative Review, published in Stem Cells Transl Med (2022) — summary generated from the PubMed abstract.
- 2022
Stem Cells Transl Med23 citations - Level CCohort StudyPubMed
Clinical Safety and Effectiveness of Adipose-Derived Stromal Cell vs Stromal Vascular Fraction Injection for Treatment of Knee Osteoarthritis: 2-Year Results of Parallel Single-Arm Trials.
Cohort Study with a reported sample of 80 on Knee Osteoarthritis, Osteoarthritis, published in Am J Sports Med (2022) — summary generated from the PubMed abstract.
- 2022
- n = 80
Am J Sports Med24 citations - Level BClinical TrialPubMed
Evaluation of safety, feasibility and efficacy of intra-ovarian transplantation of autologous adipose derived mesenchymal stromal cells in idiopathic premature ovarian failure patients: non-randomized clinical trial, pha
Clinical Trial with a reported sample of 3 on Hair & Scalp, published in J Ovarian Res (2021) — summary generated from the PubMed abstract.
- 2021
- n = 3
J Ovarian Res59 citations - Level BClinical TrialPubMed
Treatment of chronic diabetic foot ulcers with adipose-derived stromal vascular fraction cell injections: Safety and evidence of efficacy at 1 year.
Clinical Trial with a reported sample of 51 on Type 2 Diabetes, Diabetic Foot, Chronic Wound, published in Stem Cells Transl Med (2021) — summary generated from the PubMed abstract.
- 2021
- n = 51
Stem Cells Transl Med54 citations - Level ASystematic ReviewPubMed
The safety and efficacy of autologous adipose-derived stromal vascular fraction for nonscarring alopecia: A systematic review.
Systematic Review with a reported sample of 188 on Scar, Hair Loss, Hair Regeneration, published in Arch Dermatol Res (2021) — summary generated from the PubMed abstract.
- 2021
- n = 188
Arch Dermatol Res6 citations - Level CCase Report / SeriesPubMed
Efficacy and safety of autologous adipose-derived stromal vascular fraction enriched with platelet-rich plasma in flap repair of transsphincteric cryptoglandular fistulas.
Case Report / Series with a reported sample of 38 on Chronic Wound, Scar, Immune Modulation, Autoimmune Research, published in Tech Coloproctol (2021) — summary generated from the PubMed abstract.
- 2021
- n = 38
Tech Coloproctol15 citations - Level CProspective StudyPubMed
Safety and Efficacy of Human Adipose-Derived Stromal/Stem Cell Therapy in an Immunocompetent Murine Pressure Ulcer Model.
Prospective Study on Chronic Wound, published in Stem Cells Dev (2020) — summary generated from the PubMed abstract.
- 2020
Stem Cells Dev15 citations - Level DAnimal StudyPubMed
Human adipose-derived stromal vascular fraction: characterization, safety and therapeutic potential in an experimental mouse model of articular injury.
Animal Study on Cartilage Damage, Cardiovascular Disease, published in J Stem Cells Regen Med (2020) — summary generated from the PubMed abstract.
- 2020
J Stem Cells Regen Med14 citations - Level CProspective StudyPubMed
Safety of adipose-derived cell (stromal vascular fraction - SVF) augmentation for surgical breast reconstruction in cancer patients.
Prospective Study with a reported sample of 56, published in Adv Clin Exp Med (2018) — summary generated from the PubMed abstract.
- 2018
- n = 56
Adv Clin Exp Med34 citations - Level BClinical TrialPubMed
Cryopreserved Off-the-Shelf Allogeneic Adipose-Derived Stromal Cells for Therapy in Patients with Ischemic Heart Disease and Heart Failure-A Safety Study.
Clinical Trial on Cardiovascular Disease, published in Stem Cells Transl Med (2017) — summary generated from the PubMed abstract.
- 2017
Stem Cells Transl Med95 citations - Level BClinical TrialPubMed
Safety of intrathecal autologous adipose-derived mesenchymal stromal cells in patients with ALS.
Clinical Trial on Back & Spine, published in Neurology (2016) — summary generated from the PubMed abstract.
- 2016
Neurology93 citations - Level DAnimal StudyPubMed
The effect and safety of polylactic acid and adipose-derived stromal vascular fraction cell as an injectable bulking agent in urologic field: a 24-week follow-up study.
Animal Study, published in J Biomed Mater Res B Appl Biomater (2014) — summary generated from the PubMed abstract.
- 2014
J Biomed Mater Res B Appl Biomater8 citations - Level BClinical TrialPubMed
Safety, tolerability and potential efficacy of injection of autologous adipose-derived stromal vascular fraction in the fingers of patients with systemic sclerosis: an open-label phase I trial.
Clinical Trial on Autoimmune Research, published in Ann Rheum Dis (2014) — summary generated from the PubMed abstract.
- 2014
Ann Rheum Dis126 citations - Level DAnimal StudyPubMed
Safety and immunomodulatory effects of allogeneic canine adipose-derived mesenchymal stromal cells transplanted into the region of the lacrimal gland, the gland of the third eyelid and the knee joint.
Animal Study on Osteoarthritis, Immune Modulation, published in Cytotherapy (2013) — summary generated from the PubMed abstract.
- 2013
Cytotherapy40 citations
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406